The drug 3,4-Methylenedioxymethamphetamine, also known as MDMA or ”Molly,” is a schedule I drug with no current medical use, according to the U.S. Drug Enforcement Administration (DEA). However, a recent study conducted by Jennifer M. Mitchell, Michael Bogenschutz and 36 other pioneers in therapeutic studies, stands to challenge that classification. More specifically, the researchers are … Continue reading MDMA Inches Toward FDA Approval for the Treatment of PTSD